These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 3288029

  • 1. Combination drug therapy for familial combined hyperlipidemia.
    East C, Bilheimer DW, Grundy SM.
    Ann Intern Med; 1988 Jul 01; 109(1):25-32. PubMed ID: 3288029
    [Abstract] [Full Text] [Related]

  • 2. Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.
    Zambón D, Ros E, Rodriguez-Villar C, Laguna JC, Vázquez M, Sanllehy C, Casals E, Sol JM, Hernández G.
    Metabolism; 1999 Jan 01; 48(1):47-54. PubMed ID: 9920144
    [Abstract] [Full Text] [Related]

  • 3. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.
    Circulation; 1989 Jan 01; 79(1):16-28. PubMed ID: 2642754
    [Abstract] [Full Text] [Related]

  • 4. Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia.
    Houlston R, Quiney J, Watts GF, Lewis B.
    J R Soc Med; 1988 May 01; 81(5):274-6. PubMed ID: 3164409
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of gemfibrozil or simvastatin on apolipoprotein-B-containing lipoproteins, apolipoprotein-CIII and lipoprotein(a) in familial combined hyperlipidaemia.
    Bredie SJ, Westerveld HT, Knipscheer HC, de Bruin TW, Kastelein JJ, Stalenhoef AF.
    Neth J Med; 1996 Aug 01; 49(2):59-67. PubMed ID: 8824106
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study.
    Ojala JP, Helve E, Tikkanen MJ.
    Cardiology; 1990 Aug 01; 77 Suppl 4():39-49. PubMed ID: 2073671
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
    Illingworth DR.
    Ann Intern Med; 1984 Nov 01; 101(5):598-604. PubMed ID: 6567462
    [Abstract] [Full Text] [Related]

  • 13. The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment.
    Korhonen T, Hannuksela ML, Seppänen S, Kervinen K, Kesäniemi YA, Savolainen MJ.
    Eur J Clin Pharmacol; 1999 Feb 01; 54(12):903-10. PubMed ID: 10192749
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC.
    Br J Clin Pharmacol; 1998 Mar 01; 45(3):265-9. PubMed ID: 9517370
    [Abstract] [Full Text] [Related]

  • 15. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
    Malloy MJ, Kane JP, Kunitake ST, Tun P.
    Ann Intern Med; 1987 Nov 01; 107(5):616-23. PubMed ID: 3662275
    [Abstract] [Full Text] [Related]

  • 16. Use of niacin, statins, and resins in patients with combined hyperlipidemia.
    Brown BG, Zambon A, Poulin D, Rocha A, Maher VM, Davis JW, Albers JJ, Brunzell JD.
    Am J Cardiol; 1998 Feb 26; 81(4A):52B-59B. PubMed ID: 9526815
    [Abstract] [Full Text] [Related]

  • 17. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 18. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.
    Vega GL, East C, Grundy SM.
    Arteriosclerosis; 1989 Feb 01; 9(1 Suppl):I135-44. PubMed ID: 2912427
    [Abstract] [Full Text] [Related]

  • 19. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
    Weisweiler P, Merk W, Jacob B, Schwandt P.
    Eur J Clin Pharmacol; 1986 Feb 01; 30(2):191-4. PubMed ID: 3709644
    [Abstract] [Full Text] [Related]

  • 20. A comparison of lovastatin, an HMG-CoA reductase inhibitor, with gemfibrozil, a fibrinic acid derivative, in the treatment of patients with diabetic dyslipidemia.
    Bell DS.
    Clin Ther; 1995 Feb 01; 17(5):901-10. PubMed ID: 8595642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.